ACETAMINOPHEN AND IBUPROFEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Acetaminophen And Ibuprofen, and what generic alternatives are available?
Acetaminophen And Ibuprofen is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, Dr Reddys, Glenmark Pharms Ltd, Granules, L Perrigo Co, and Marksans Pharma. and is included in seven NDAs.
The generic ingredient in ACETAMINOPHEN AND IBUPROFEN is acetaminophen; ibuprofen. There are sixty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the acetaminophen; ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetaminophen And Ibuprofen
A generic version of ACETAMINOPHEN AND IBUPROFEN was approved as acetaminophen; ibuprofen by L PERRIGO CO on February 28th, 2023.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACETAMINOPHEN AND IBUPROFEN?
- What are the global sales for ACETAMINOPHEN AND IBUPROFEN?
- What is Average Wholesale Price for ACETAMINOPHEN AND IBUPROFEN?
Summary for ACETAMINOPHEN AND IBUPROFEN
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 34 |
| Clinical Trials: | 243 |
| DailyMed Link: | ACETAMINOPHEN AND IBUPROFEN at DailyMed |
Recent Clinical Trials for ACETAMINOPHEN AND IBUPROFEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | Phase 4 |
| Jessyka Lighthall | Phase 3 |
| Rutgers, The State University of New Jersey | Phase 4 |
Pharmacology for ACETAMINOPHEN AND IBUPROFEN
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for ACETAMINOPHEN AND IBUPROFEN
ACETAMINOPHEN AND IBUPROFEN is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting ACETAMINOPHEN AND IBUPROFEN
PATENT CHALLENGE
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | ACETAMINOPHEN AND IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 218359-001 | Mar 26, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Marksans Pharma | ACETAMINOPHEN AND IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 216994-001 | Jul 10, 2023 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Ltd | ACETAMINOPHEN AND IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 218311-001 | Apr 26, 2024 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bionpharma | ACETAMINOPHEN AND IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 216999-001 | Aug 1, 2023 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
